Injections derived from umbilical cord blood have caused life-threatening infections, health officials say, prompting new warnings about the risks of unproven stem cell treatments.
Liveyon, a company in Yorba Linda, Calif., sells tiny vials of a solution it says is derived from umbilical cord blood, which it claims is an especially potent source of healing stem cells.
The SEC barred him in 2014 from the securities industry after he made “material misstatements” and committed “fraud and deceit,” according to a settlement agreement between the SEC and Kosolcharoen. In an administrative hearing on the case, the SEC said Kosolcharoen worked for a Dallas-based medical insurance company, Global Corporate Alliance, which SEC officials described as “a $10 million Ponzi scheme that victimized at least 80 investors.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Pharma giants are betting billions on gene therapies that could fundamentally change how we treat diseasesRecent deals like Roche's $4.8 billion bet on Spark and Novartis' $8.7 billion acquisition of AveXis show that big pharma is betting big on gene therapy.
Baca lebih lajut »